G
G. Bianchi Porro
Researcher at University of Milan
Publications - 266
Citations - 9835
G. Bianchi Porro is an academic researcher from University of Milan. The author has contributed to research in topics: Helicobacter pylori & Ranitidine. The author has an hindex of 50, co-authored 266 publications receiving 9501 citations. Previous affiliations of G. Bianchi Porro include University of Bologna.
Papers
More filters
Journal ArticleDOI
Current European concepts in the management of Helicobacter pylori infection the Maastricht Consensus Report
Peter Malfertheiner,Francis Mégraud,Colm O'Morain,D. Bell,G. Bianchi Porro,Michel Arthur Deltenre,D. Forman,Giovanni Gasbarrini,B. Jaup,J. J. Misiewicz,J. G. Pajarés,Mario Quina,E. Rauws +12 more
TL;DR: There was consensus that treatment regimens should be simple, well tolerated and achieve an eradication rate of over 80% on an intention to treat basis.
Journal ArticleDOI
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
Sandro Ardizzone,Giovanni Maconi,Antonio Russo,Venerina Imbesi,Elisabetta Colombo,G. Bianchi Porro +5 more
TL;DR: Azathioprine is significantly more effective than 5-aminosalicylic acid in inducing clinical and endoscopic remission and avoiding steroid requirement in the treatment of steroid dependent ulcerative colitis.
Journal ArticleDOI
Gastroscopic evaluation of anti-inflammatory agents.
I. Caruso,G. Bianchi Porro +1 more
TL;DR: A lack of correlation between the patients9 subjective complaints of gastric discomfort and the gastroscopic findings emphasises the unreliability of patients9 complaints and the importance of gastroscopy in assessing gastric tolerance.
Journal ArticleDOI
Preparation, Premedication and Surveillance
M. Lazzaroni,G. Bianchi Porro +1 more
TL;DR: As expected in view of the drug's known pharmacological properties, the quality of sedation was better and recovery time was shorter in patients treated with propofol, however, important questions involving the narrow therapeutic range and the mode of administration of Propofol (by endoscopists or nurses, or by anesthesiologists) remain open.
Journal ArticleDOI
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Sandro Ardizzone,Simona Bollani,Paolo Bettica,Maurizio Bevilacqua,P. Molteni,G. Bianchi Porro +5 more
TL;DR: There is a difference between Crohn’s disease and ulcerative colitis, and altered bone metabolism in inflammatory bowel disease is found to be a cause for concern.